Skip to the page

Data / Form D filings / Next Science Ltd

Next Science Ltd: Form D filing

Next Science Ltd, a biotechnology company in Jacksonville, FL, filed a Form D with the SEC in 2023. The latest, on September 25, 2023, reports $807,474 sold of a $807,474 offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10550 DEERWOOD PARK BLVD #300, Jacksonville, FL, 32256
Phone
61 419 414 415
Industry
Biotechnology
Entity type
Other (Australian Public Company, Limited By Shares)
Incorporated in
Australia
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1993519

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 25, 2023New notice$807,474$807,47418Aug 29, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Aileen StockburgerDirector
Gillian NairnExecutive Officer
Harry Hall IVDirector
Dan SpiraDirector
Matthew MynttiExecutive Officer
Marc ZimmermanExecutive Officer
Grant HummelDirector
Jon SwansonExecutive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Sep 25, 2023 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Next Science Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.